Department of Medical Sciences, Geriatrics Unit and Gerontology-Geriatrics Research Laboratory, IRCCS Scientific Institute and Regional General Hospital "Casa Sollievo della Sofferenza", San Giovanni Rotondo, Italy.
Department of Medical Sciences, Division of Internal Medicine and Chronobiology Unit, IRCCS Scientific Institute and Regional General Hospital "Casa Sollievo della Sofferenza", San Giovanni Rotondo, Italy.
Mol Neurobiol. 2019 Mar;56(3):1908-1920. doi: 10.1007/s12035-018-1200-z. Epub 2018 Jul 5.
Klotho, encoded by the KL gene, is a single-pass transmembrane protein and a circulating factor that plays a key role in cellular metabolism and body homeostasis and has been associated with age-related diseases. Alterations of this protein seem to influence the development of serotonergic neurons and could play a role in major depression in the elderly. Pretreatment of neurons with Klotho protein can avoid neuronal injury related to the toxic amyloid-β and glutamate, centrally related to the pathogenesis of Alzheimer's disease (AD), in order that Klotho protein could play a neuroprotective role in AD patients. Late-life depression, mild cognitive impairment, and dementia are different nosological entities but share common neurobiological facets and could represent a clinical continuum. Enhancement of Klotho levels in the early stages of the disease could represent a therapeutic strategy to prevent further deterioration and to ameliorate the outcome of elderly AD patients with or without major depression.
Klotho 是由 KL 基因编码的单次跨膜蛋白和循环因子,在细胞代谢和体内平衡中发挥关键作用,并与年龄相关疾病有关。这种蛋白质的改变似乎会影响 5-羟色胺能神经元的发育,并可能在老年人的重度抑郁症中发挥作用。用 Klotho 蛋白预处理神经元可以避免与阿尔茨海默病(AD)发病机制中心相关的毒性淀粉样蛋白-β和谷氨酸相关的神经元损伤,以便 Klotho 蛋白在 AD 患者中发挥神经保护作用。老年期抑郁症、轻度认知障碍和痴呆是不同的疾病实体,但具有共同的神经生物学特征,可能代表一种临床连续体。在疾病早期增加 Klotho 水平可能是一种治疗策略,可以防止进一步恶化,并改善有或没有重度抑郁症的老年 AD 患者的预后。